Boundless Bio, Inc.
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.96% | -1.15% | -11.55% | -23.61% | -32.22% |
| Total Depreciation and Amortization | 15.19% | 19.58% | 18.02% | 15.97% | 13.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.42% | 82.01% | 155.85% | 155.58% | 111.24% |
| Change in Net Operating Assets | 306.32% | 305.60% | 170.65% | -42.34% | -110.01% |
| Cash from Operations | 23.31% | 8.51% | 1.25% | -17.91% | -29.85% |
| Capital Expenditure | 78.47% | 74.85% | 47.36% | -298.73% | -300.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 262.73% | 378.71% | 198.52% | 7.18% | 37.37% |
| Cash from Investing | 244.83% | 320.05% | 191.29% | 2.63% | 31.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.85% | -99.75% | -99.75% | 44,239.52% | 51,093.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 99.74% | 19.50% | -71.22% |
| Cash from Financing | -99.84% | -99.74% | -99.75% | -6.39% | -8.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -402.64% | -231.09% | -67.43% | -343.82% | -77.46% |